Learn more about AML at http://www.YouAndAML.com
In this video, expert Dr. Sandra Kurtin describes some of the risk factors for acute myeloid leukemia, or AML. Age is a main risk factor, and most people diagnosed with AML are over 65. Other risk factors include smoking, having radiation therapy or some types of chemotherapy, being exposed to a chemical called benzene and having certain genetic changes.

"""I discovered a lump in my neck too, which my GP picked up on straightaway and sent me to hospital under the two-week referral.""

Ann Hope had been experiencing sore throats, breathlesness and vomiting before a lump appeared on her neck. Thankfully, her GP knew something was wrong and sent her for tests.

In this video, Ann recounts her #SpotLeukaemia story.

More about our Spot Leukaemia campaign can be found by visiting www.spotleukaemia.org.uk

The ASH Clinical Practice Guidelines for Acute Myeloid Leukemia (AML) covers the treatment of acute myeloid leukemia in older adults.

Learn more and access the full guidelines: www.hematology.org/AMLguidelines

Learn more about AML at http://www.YouAndAML.com
Dr. David Steensma, an expert on acute myeloid leukemia (AML), explains that doctors do not yet know exactly how to prevent AML. In the future, we may have screening tests for adults. For now, avoiding smoking and tobacco products, or quitting smoking if you smoke, may reduce your risk. Although some AML can develop after treatment for another type of cancer, the benefits of that treatment may outweigh the risk of getting treatment-related AML, or tAML. It is important to talk with your doctor about this.

What might acute myeloid leukemia (AML) patients experience for symptoms, treatment, and coping with AML? AML patient and Empowerment Lead Art Flatau shares the experience of his AML journey from diagnosis, through treatment and AML survival, and advancements in AML treatments. Art also shares his empowerment advice for patients and care partners to ensure optimal care and how he has found a sense of purpose in patient advocacy efforts.

Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome. Subscribe now to receive the latest news on cancer treatment and research: https://powerfulpatients.org/connect

Learn more about AML at http://www.YouAndAML.com
Expert Dr. David Steensma explains that secondary acute myeloid leukemia, or secondary AML, is AML that happens in someone who has another condition, such as myelodysplastic syndrome (MDS) or another blood disorder. It can also happen in people who have certain conditions such as Down syndrome. AML-MRC and tAML are two types of secondary AML because they happen in people who already have, or had, another condition.

Learn more about MDS at http://www.YouAndMDS.com
MDS experts, Dr Rafael Bejar and Dr Casey O’Connell, discuss how acute myeloid leukemia (AML) relates to MDS. About 30 percent of people with MDS develop a life-threatening blood cancer called AML. The risk of AML depends on the type of MDS you have and other factors. To help confirm a diagnosis of AML, a bone marrow biopsy is performed to capture all the changes (including genetic) that led to the condition.